Viewing Study NCT01355393


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2025-12-25 @ 11:31 PM
Study NCT ID: NCT01355393
Status: COMPLETED
Last Update Posted: 2020-02-10
First Post: 2011-05-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer
Sponsor: University of Washington
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module